Suppr超能文献

5-羟色胺2受体拮抗剂MDL 100907作为一种潜在非典型抗精神病药物的特性:行为学、电生理学及神经化学研究

Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.

作者信息

Sorensen S M, Kehne J H, Fadayel G M, Humphreys T M, Ketteler H J, Sullivan C K, Taylor V L, Schmidt C J

机构信息

Marion Merrell Dow Research Institute, Cincinnati, Ohio.

出版信息

J Pharmacol Exp Ther. 1993 Aug;266(2):684-91.

PMID:8102646
Abstract

Progress toward understanding the role of the 5-hydroxytryptamine (5-HT)2 receptor in the therapy for schizophrenia has been hampered by the lack of highly selective antagonists. We now report on the effects of MDL 100,907 [R(+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenylethyl)]-4-piperidine-methanol], a highly selective and potent 5-HT2 receptor antagonist, in behavioral, electrophysiological and neurochemical models of antipsychotic activity and extrapyramidal side-effect liability. In mice, MDL 100,907 blocked amphetamine-stimulated locomotion at doses that did not significantly affect apomorphine-stimulated climbing behavior. Neither MDL 100,907 nor clozapine reduced apomorphine-induced stereotypies or produced catalepsy in rats. MDL 100,907 blocked the slowing of ventral tegmental area (A10) dopaminergic neurons by amphetamine but, like clozapine, produced only small increases in the number of active substantia nigra zona compacta (A9) and A10 dopamine neurons after acute administration. When administered chronically, MDL 100,907 and clozapine selectively reduced the number of spontaneously active A10 neurons, whereas haloperidol reduced activity in both the A9 and A10 regions. Consistent with their acute effect on A9 and A10 activity, neither MDL 100,907 nor clozapine increased dopamine metabolism in the striatum or nucleus accumbens, whereas acute haloperidol accelerated dopamine turnover in both regions. The administration of the dopamine uptake blocker amfonelic acid with haloperidol produced a massive increase in DA metabolism characteristic of typical antipsychotics. In contrast, MDL 100,907 and clozapine were without effect on dopamine turnover when given in the presence of amfonelic acid. These data indicate that MDL 100,907 has a clozapine-like profile of potential antipsychotic activity with low extrapyramidal sid-effect liability.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

由于缺乏高选择性拮抗剂,在了解5-羟色胺(5-HT)2受体在精神分裂症治疗中的作用方面进展受阻。我们现在报告一种高选择性强效5-HT2受体拮抗剂MDL 100,907 [R(+)-α-(2,3-二甲氧基苯基)-1-[2-(4-氟苯基乙基)]-4-哌啶甲醇]在抗精神病活性和锥体外系副作用倾向的行为、电生理和神经化学模型中的作用。在小鼠中,MDL 100,907在不显著影响阿扑吗啡刺激的攀爬行为的剂量下阻断苯丙胺刺激的运动。MDL 100,907和氯氮平均未减少阿扑吗啡诱导的刻板行为,也未在大鼠中产生僵住症。MDL 100,907阻断苯丙胺对腹侧被盖区(A10)多巴胺能神经元的减慢作用,但与氯氮平一样,急性给药后仅使黑质致密部(A9)和A10多巴胺能神经元的活动数量略有增加。长期给药时,MDL 100,907和氯氮平选择性减少自发活动的A10神经元数量,而氟哌啶醇则降低A9和A10区域的活动。与它们对A9和A10活动的急性作用一致,MDL 100,907和氯氮平均未增加纹状体或伏隔核中的多巴胺代谢,而急性氟哌啶醇加速这两个区域的多巴胺周转。将多巴胺摄取阻滞剂安非他明酸与氟哌啶醇一起给药会产生典型抗精神病药物特有的多巴胺代谢大量增加。相比之下,在安非他明酸存在的情况下给药时,MDL 100,907和氯氮平对多巴胺周转没有影响。这些数据表明,MDL 100,907具有类似氯氮平的潜在抗精神病活性特征,锥体外系副作用倾向较低。(摘要截短为250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验